Posted in Market

Salarius regains full Nasdaq compliance ahead of planned merger with Decoy Therapeutics

Reporter



Salarius regains full Nasdaq compliance ahead of planned merger with Decoy Therapeutics



Source link

You May Also Like

Moving NASA Space Shuttle to Texas from DC Could Damage It, Experts Say

Sarah Paulson Publicly Grieves Longtime Friend Diane Keaton

Leave a Reply

Your email address will not be published. Required fields are marked *